Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases
NCT ID: NCT04119908
Last Updated: 2023-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
400 participants
INTERVENTIONAL
2023-05-24
2028-05-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognostic Value of Implementing VCE on Top in Constitutional VWD-patients With GI-bleeding
NCT04466878
Cardiovascular and Venous Thromboembolism Disease in Patients with Von Willebrand Disease in the French West
NCT05773638
Update in VWD Laboratory Diagnosis
NCT03896997
Frequency of Hemorrhages Associated With the Functional Anomalies of Willebrand Factor in Emergency Patients
NCT03070912
Impact of Von Willebrand Factor and Its Multimers on Angiogenesis
NCT04810702
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with haemorrhagic disease
Patients with von Willebrand disease or Patients with Glanzmann Thrombasthenia
Sublingual videomicroscopy
Measurement of sublingual capillary density by video microscopy
blood sample
Collection of citrate tubes of 5 mL at baseline and at 36 months
Control group
Patients with moderate or severe hemophilia A or women carrying the hemophilia gene
Sublingual videomicroscopy
Measurement of sublingual capillary density by video microscopy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sublingual videomicroscopy
Measurement of sublingual capillary density by video microscopy
blood sample
Collection of citrate tubes of 5 mL at baseline and at 36 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Refusal of consent
* Person benefiting from a system of legal protection
* Pregnant patient
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antoine Rauch, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Lille
Lille, Nord, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Antoine Rauch, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A01601-56
Identifier Type: OTHER
Identifier Source: secondary_id
2019_05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.